CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Patrick Christmas

Executive Vice President & Chief Strategy and Legal Officer, Regenxbio

Verified interview transcripts, podcast appearances, and direct quotes from Patrick Christmas, Executive Vice President & Chief Strategy and Legal Officer at Regenxbio. AI-verified speaker identity with full-text searchable transcripts.

Recent appearances

  • REGENXBIO

    January 05, 2026 · 📺 Alliance for Regenerative Medicine

    Patrick Christmas, Chief Strategy and Legal Officer REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field of AAV gene therapy. REGENXBIO is advancing a late-stage pipeline of one-time treatments for rare and retinal diseases, including RGX-202 for the treatment of Duchenne; clemidsogene lanparvovec (RGX-121) for the treatment of MPS II and RGX-111 for the treatment of MPS I, both in partnership with Nippon Shinyaku; and surabgene lomparvovec (ABBV-RGX-314) for the treatme…

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →